Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Paroxysmal non-kinesigenic dyskinesia (PNKD) is a form of paroxysmal dyskinesia, characterized by attacks of dystonic or choreathetotic movements precipitated by stress, fatigue, coffee or alcohol intake or menstruation.
No HPO annotations are available for this condition.
Familial paroxysmal nonkinesigenic dyskinesia (PNKD) is characterized by unilateral or bilateral involuntary movements. Attacks are often precipitated by caffeinated beverages but can also be spontaneous or triggered by excitement, stress, fatigue, and very rarely by sudden movements or prolonged exercise . The clinical description of this disorder is based on the following citations, unless otherwise noted: , , , , , . Age of onset is typically in infancy or childhood but can in rare cases be as late as age 50 years. The attacks predominantly involve dystonic posturing with some choreic and ballistic movements. Individuals often experience an aura-like sensation preceding the attacks. Attacks are never associated with a loss of consciousness and never occur during sleep.
Familial paroxysmal nonkinesigenic dyskinesia (PNKD) should be suspected in individuals with the following features:
Attacks:
Of dystonia, chorea, and/or ballismus, with onset during infancy
That can be provoked by alcohol or caffeine
No approved treatments are currently available for paroxysmal nonkinesigenic dyskinesia. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with familial paroxysmal nonkinesigenic dyskinesia (PNKD), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Monitor medication requirements and dosage.
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
Estimated prevalence: 1-9 in 1,000,000 (Rare).
No clinical trials have been registered for paroxysmal nonkinesigenic dyskinesia.
9 publications have been identified in PubMed for paroxysmal nonkinesigenic dyskinesia. Research spans Case Report / Case Series (44%), Basic Science / Preclinical (22%), and Review / Meta-Analysis (11%).
Makrygianni M (2026). [PMID: 41944352](https://pubmed.ncbi.nlm.nih.gov/41944352/). *Curr Opin Neurol*. [Review / Meta-Analysis]
Wang Q (2026). [PMID: 41391423](https://pubmed.ncbi.nlm.nih.gov/41391423/). *Seizure*. [Epidemiology / Natural History]
Zhang W (2026). [PMID: 41664728](https://pubmed.ncbi.nlm.nih.gov/41664728/). *Cureus*. [Case Report / Case Series]
Ebner S (2025). [PMID: 40812354](https://pubmed.ncbi.nlm.nih.gov/40812354/). *Neuropediatrics*. [Case Report / Case Series]
Huang Y (2025). [PMID: 40167379](https://pubmed.ncbi.nlm.nih.gov/40167379/). *Acta physiologica (Oxford, England)*. [Basic Science / Preclinical]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
Lasting several minutes to hours
Rarely occurring more than once per day
No loss of consciousness during an attack
Poor response to pharmacologic treatment (although clonazepam or diazepam can be effective)
Normal:
Interictal neurologic examination
Brain MRI
EEG
Family history consistent with autosomal dominant inheritance
The diagnosis of familial PNKD is established in an individual with the above by identification of a heterozygous pathogenic variant...
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
Paroxysmal dyskinesias have been reported in individuals with the following disorders (brain MRI examination is important to rule out these etiologies): • Basal ganglia lesions caused by multiple sclerosis • Tumors • Vascular lesions including moyamoya disease • Penetrating brain injury (e.g., right frontal) • Central pontine myelinolysis Focal seizures can present with paroxysms of dystonia; EEG is an essential part of the investigations. Autoimmune disorders. Dyskinesias seen in association with rheumatic fever (Sydenham's chorea) are associated with a raised anti-streptolysin O (ASO) titer and normal cerebrospinal fluid. PNKD has also been reported as a manifestation of antiphospholipid antibody syndrome . Chorea gravidarum can present with paroxysms of chorea in the first trimester of pregnancy and usually resolves after delivery. Other. Paroxysmal chorea can also be seen with systemic lupus erythematosus, diabetes mellitus, hypoparathyroidism, pseudohypoparathyroidism, and thyrotoxicosis. The relevant laboratory testing should be done if these etiologies are being considered . Inherited Causes of Paroxysmal Dyskinesia Table 2. Disorders to Consider in the Differential Diagnosis of Familial PNKD
MOI /Category | Disorder | Gene(s) | Age of Onset | Neurologic Presentation |
|---|---|---|---|---|
AD /Paroxysmal dyskinesias | Familial paroxysmal kinesigenic dyskinesia(See PRRT2-Associated Paroxysmal Movement Disorders.) | PRRT21 | Typically childhood adolescence | Attacks of dyskinesia:; Are triggered by sudden movement;; Last secs to mins;; May occur 100x/day;; Do not cause loss of consciousness, persons have normal ictal EEG. Clinical spectrum can incl:; Episodic ataxia;; Hemiplegic migraine. |
SLC2A1 | Infancy | PED:; Lasts 5-30 mins;; Can be part of a complex neurologic syndrome incl epilepsy, DD, ataxia, spasticity. | — | — |
Autosomal dominant nocturnal frontal lobe epilepsy | Many | Infancy to adulthood | Incl dystonia, chorea, ballism; Episodes generally occur during non-REM sleep, often evoking arousal followed again by sleep.; Persons are able to recall the episodes in the morning. KCNMA1-related paroxysmal dyskinesia (OMIM 609446) | — |
KCNMA1 | Childhood | Attacks of PNKD can be triggered by alcohol or coffee.; Persons also have epilepsy /or DD. ADCY5-related dyskinesia | — | — |
ADCY5 | Childhood | Choreiform, myoclonic, /or dystonic movements w/attacks of paroxysmal dyskinesia, exacerbated by anxiety, not precipitated by startle, caffeine, or alcohol Alternating hemiplegia of childhood (See ATP1A3-Related Neurologic Disorders.) | — | — |
ATP1A3 | Childhood | Alternating (i.e., from one side of the body to the other) attacks of dystonia w/a typical rostrocaudal distribution that may be triggered by fever, trauma, or stress AD /Dyskin... | — | — |
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
Consultation with a clinical geneticist and/or genetic counselor
Avoid triggers (e.g., caffeine, alcohol). Response to pharmacologic treatment is poor; however, clonazepam or diazepam can be effective in at least 50% of individuals with PNKD, although response may decrease over time.
A child age four years with familial PNKD responded to gabapentin .
reported individuals from a family with PNKD who responded favorably to levetiracetam.
reported individuals with severe PNKD who responded to acetazolamide.
Monitor medication requirements and dosage.
See for issues related to testing of at-risk relatives for genetic counseling purposes.
Pregnant women who are on anticonvulsant therapy for familial PNKD are advised to take folic acid (5 mg/day). Because of the risk of teratogenic effects related to anticonvulsants, women with mild symptoms related to familial PNKD may consider discontinuing anticonvulsant therapy during pregnancy. See MotherToBaby for access further information on medication use during pregnancy.
...
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Familial Paroxysmal Nonkinesigenic Dyskinesia"
View trials for paroxysmal nonkinesigenic dyskinesia
Harvey S (2025). [PMID: 40132247](https://pubmed.ncbi.nlm.nih.gov/40132247/). *European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society*. [Case Report / Case Series]
Tiniakou I (2024). [PMID: 38608038](https://pubmed.ncbi.nlm.nih.gov/38608038/). *Science immunology*. [Basic Science / Preclinical]
Hara M (2024). [PMID: 39211314](https://pubmed.ncbi.nlm.nih.gov/39211314/). *eNeurologicalSci*. [Clinical Trial Publication]